Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Cas No. | 1425381-60-7 |
|---|---|
| Purity | ≥98% |
| Formula | C24H28N8O2 |
| Formula Wt. | 460.54 |
| IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
| Synonym | ASN-002, ASN002 |
| Appearance | Yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
Triazole; 14-α demethylase inhibitor, potentia...
γ-Secretase inhibitor.
RET inhibitor.
β-lactamase inhibitor.
Impurity of diclofenac
Dihydropyridine; L-type and T-type Ca2+ channel...
Endogenous peptide, involved in paracrine and a...
Peptide, HIV-1 RT A2.1 epitope.
Dihydrofolate reductase inhibitor.
Endogenous NMDA receptor antagonist.
Labdane diterpene found in Andrographis.
FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor.<...
Citalopram analog
Endogenous calcitonin-family peptide, involved ...
AT1 inhibitor.
Adenosine A2A agonist.
NSAID; COX-1/2 inhibitor.
Fermentation impurity
Fluoroquinolone; topoisomerase IV and bacterial...
Non-depolarizing NMJ blocker; AChR antagonist.<...